Tanuja Narayansamy Gengiah (Tanuja N Gengiah)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Coronavirus Disease

Top Venues

Health SA = SA Gesondheid

This page only lists publications with an associated author ORCID identifier.

Publications

Tanuja Narayansamy Gengiah, Donavan C Naidoo, Nomcebo Maduma, Saien Govender, Sherishka Dhindayal, Lara Lewis
COVID-19 vaccine hesitancy in KwaZulu-Natal, South Africa: A survey of unvaccinated adults. Health SA = SA Gesondheid 29 (2024)
Tanuja Narayansamy Gengiah, Donavan C Naidoo, Nomcebo Maduma, Saien Govender, Sherishka Dhindayal, Lara Lewis
COVID-19 vaccine hesitancy in KwaZulu-Natal, South Africa: A survey of unvaccinated adults. Health SA = SA Gesondheid 29 (2024)
Sharana Mahomed, Sharana Mahomed, Disebo Potloane, Izukanji T Sikazwe, Edmund Capparelli, Ishana Harkoo, Tanuja Narayansamy Gengiah, Nonhlanhla Yende Zuma, Farzana Osman, Leila Mansoor, Derseree Archary, Nqobile Myeni, Precious Radebe, Natasha Samsunder, Nicole Doria Rose, Kevin Carlton, Lucio Gama, Richard A Koup, Sandeep Narpala, Leonid Serebryannyy, Penny Moore, Carolyn Williamson, Bruno Pozzetto, Catherine Hankins, Lynn Morris, Quarraisha Abdool Karim, Salim Abdool Karim
Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial. BMJ open 13 (8) (2023)
Hilton Humphries, Michele Upfold, Gethwana Mahlase, Makhosazana Mdladla, Tanuja Narayansamy Gengiah, Quarraisha Abdool Karim
Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision. PloS one 17 (1) (2022)
Tanuja Narayansamy Gengiah, Quarraisha Abdool Karim, Ishana Harkoo, Leila Mansoor, Nonhlanhla Yende Zuma, Precious Radebe, Natasha Samsunder, Cheryl Baxter, B Maharaj, Marc M Baum, John A Moss, Bruno Pozzetto, Catherine Hankins, Salim Abdool Karim
CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women. BMJ open 12 (1) (2022)